No description available.

Master of Public Health - MPH / Hospital acquired infections are a huge public health concern, contributing to increased hospitalisation and death in developing countries. Infection prevention and control (IPC) is a discipline which relies on practical evidence-based approaches to preventing both patients and health workers from hospital avoidable infections. However, most of these infections, in many developing countries including Zimbabwe can be attributed to lack of compliance with infection prevention and control measures by health care workers. / 2023

Health care-associated and hospital-acquired infections are two entities associated with increased morbidity and mortality. They are highly costly and constitute a great burden to the health care system. Vitamin D deficiency (< 20 ng/ml) is prevalent and may be a key contributor to both acute and chronic ill health. Vitamin D deficiency is associated with decreased innate immunity and increased risk for infections. Vitamin D can positively influence a wide variety of microbial infections. Herein we discuss hospital-acquired infections, such as pneumonia, bacteremias, urinary tract and surgical site infections, and the potential role vitamin D may play in ameliorating them. We also discuss how vitamin D might positively influence these infections and help contain health care costs. Pending further studies, we think it is prudent to check vitamin D status at hospital admission and to take immediate steps to address existing insufficient 25-hydroxyvitamin D levels.

Background: Community acquired pneumonia causes 5,9% of deaths in elderly South Africans. Mortality rates are increased in those in whom initiation of therapy with an appropriate agent has been delayed. Whereas Mycoplasma pneumoniae and Legionella pneumophila are sensitive to the macrolides or tetracycline, they do not respond to the currently recommended first-line agents for community acquired pneumonia, penicillin or a cephalosporin. It was therefore necessary to assess the prevalence of exposure to these 2 organisms in the elderly in order to determine whether a modification in the recommendations may be justified. Methods: Study population and survey: Subjects were residents of 4 old age homes in Cape Town who were older than 60 years and willing to participate. Written consent was obtained, a demographic and medical history questionnaire was completed, and a sample of blood was drawn. Laboratory methods: The indirect fluorescent antibody tests (Zeus Scientific Inc, New Jersey, USA) were used to detect the presence of antibodies to Mycoplasma pneumoniae and Legionella pneumophila. Results: The participation rate in this study was high, with 88,4% (677/766) taking part. Seropositivity for both of these organisms was low. There were 17 participants (2, 51 %) with antibodies to mycoplasma (IgG only in 8, IgM only in 1, and both IgG and IgM in the remaining 8). Titres were low with only 1 IgM titre of 16, and only 3 IgG titres of 64. Antibodies to Legionella were demonstrated in only 9 participants (1,33%). All these titres were 128 or above. Conclusions: It is concluded that first-line therapy for community acquired pneumonia should adhere to the current guidelines published by the South African Pulmonology Society. There is no indication for the routine use of agents active against Legionella or mycoplasma. Clearly, these antibiotics should be introduced if specific pointers to infection with one of these organisms are found. Because of the low seropositivity rate, the indirect fluorescent antibody test for these 2 agents has a high specificity in this population. This may be of use in making a diagnosis in an acute infection Further studies are required to elucidate the immunological response to these organisms in elderly persons. A further survey should be done to determine the seropositivity rate to these agents in community dwelling elderly.

Healthcare-associated infections present an escalating worldwide issue, further intensified by the emergence of antimicrobial resistance and the spread of pathogens on surfaces. Current infection prevention methods have shown limited effectiveness, leading to several health issues, an overuse of antibiotics, and a continuous threat of surface recontamination. In response, extensive research has focused on bioinspired omniphobic smart coatings that effectively reduce the contact area available for pathogen attachment, achieved through an increase in surface roughness and apparent surface energy. This thesis introduces a new class of an omniphobic spray-coating, featuring hierarchical structured polydimethylsiloxane (PDMS) microparticles coated with gold nanoparticles, encompassing primary microscale (~0.23 𝜇m) and secondary nanoscale (~5 nm) buckyball and labyrinth wrinkles. This substrate-independent coating efficiently repels a wide range of liquids, including pathogens, even under harsh conditions like high temperatures, ultraviolet (UV) exposure, and abrasions. Repellency tests comparing coated and uncoated gloves revealed that uncoated gloves spread contamination to 50 secondary surfaces, while coated gloves transferred fewer bacteria and viruses to just three and two surfaces, respectively. The investigation extended to the coating's biocidal capabilities, incorporating gold nanoparticles functionalized with mercapto-silane to create a "Repel and Kill" coating. This process initiates chemisorption through thiol-gold bonding, allowing for the formation of diverse surface structures, including three-dimensional self-assembly, multilayers, and island structures. These modifications significantly enhance the roughness and hydrophobicity of the gold nanoparticles, amplifying their biocidal effectiveness. The wrinkled structure of PDMS contribute to repellency, while the functionalized gold nanoparticles play a crucial role in the antimicrobial property. This enhancement was evident in the antibacterial tests, which exhibited an immediate 99.90% reduction in bacterial adhesion for both MRSA and Pseudomonas aeruginosa (P. aeruginosa), followed by an additional 99.70% and 99.90% reduction in bacterial growth after 8 hours for MRSA and P. aeruginosa, respectively. Moreover, the coating's antiviral properties were confirmed, demonstrating a 98% reduction in the transfer of the bacterial virus Phi6. Recognizing the role of hospital fabrics as potential reservoirs for infection transmission, primarily due to their ability to sustain bacterial growth for extended periods, especially in the presence of bodily fluids, we took further steps to modify the wrinkled PDMS microparticles. This involved the incorporation of silver nanoparticles, capped with a positively charged ligand known as branched polyethyleneimine (bPEI). Additionally, we integrated a colorimetric sensor, giving rise to the "Repel, Kill, and Detect" smart coating. The transition of color from blue to green-yellow provided a tangible indicator of contamination detection based on the acidic mileu of the biofilms. To evaluate its realworld effectiveness, we conducted simulations of infection transmission in hospital environments, resulting in a remarkable reduction in pathogen adhesion from urine and feces by 99.88% and 99.79%, respectively, compared to uncoated fabrics. To further enhance the validation of our results, we employed a powerful deep learning network architecture, that determined whether the surfaces are contaminated or safe. In the face of evolving health challenges, this coating emerges as a resilient and adaptable solution, promising to enhance overall safety and alleviate the burden of infectious diseases. / Thesis / Doctor of Engineering (DEng) / The prolonged survival of pathogens on surfaces, significantly highlighted by the COVID-19 global pandemic, has intensified the urgency of addressing contamination on high-touch surfaces. Engineered surface coatings with repellent properties have emerged as a long-lasting and health-conscious solution for infection prevention and control. In this thesis, we introduce a new class of multifunctional engineered coatings featuring hierarchical structures adorned with biocidal nanoparticles and an integrated colorimetric sensor. We comprehensively investigate these coatings' multifunctional capabilities to repel, exterminate, and detect contaminants. Through specific characterization tests involving a wide range of pathogens, including viruses, bacteria, and fungi, within complex biological fluids like urine and feces, this research culminates in the development of surface coatings equipped with both antimicrobial and pathogen-sensing capabilities. In addition to advancing our understanding of surface hierarchy and chemical modifications for repellency and biocidal activity, this thesis yields insights into the dynamics of biofouling and pathogen transfer, with the overarching goal of reducing pathogen transmission via surfaces.

Background: A healthcare associated infection (HCAI) is an infection which is acquired from any healthcare establishment or context. In Sweden, one HCAI costs 107 000 SEK for the Swedish healthcare, but 50 percent of those are avoidable. The two most common HCAI are surgical site infections and urinary tract infections. Aim: The aim of this study was to describe patients experiences of suffering from healthcare associated infections. Method: The study was literature-based. Eight qualitative articles from the year 2010 to 2022 were included in the result. The articles needed to be based on describing the patients experience or perspective of suffering from a healthcare associated infection. Infections who were acquired from society were excluded. Results: The analysis of the articles resulted in three main themes and was then divided into two subthemes each. Main theme ”healthcare is failing” describes patients experienced lack of information and lack of trust in the healthcare professionals. “Physical exertion” was described as aches and pains, as well as physical limitation. “Psychological suffering” described patients experience of negative emotions and deteriorating social relationships.  Conclusion: HCAI showed substantial consequences for the patients, from distrust of the healthcare system, to suffering within emotional aspects as well as physical aspects due to pain and physical limitations. For practical implications, the authors are of the opinion that distinct information is essential to enable patients' participation in their healthcare.

Introduction. La détection précoce des infections par un système de surveillance efficace permet de mettre en œuvre des mesures de prévention et de contrôle adaptées. L’objectif de cette thèse était d’évaluer les performances d’un système de détection automatique, type syndromique, des patients à risque épidémique à partir des données du dossier médical informatisé des urgences. Population d’étude. 101001 patients ayant consulté aux urgences du groupement Nord des Hospices Civils de Lyon, entre le 01/06/2007 et le 31/03/2011, dont 10895 patients hospitalisés dans l’établissement à l’issue de la consultation. Méthode. Trois étapes ont été nécessaires. 1) Évaluation de la faisabilité d’utiliser les données structurées et textuelles, à l’aide d’une application de traitement automatisé des données textuelles. 2) Construction et évaluation d’algorithmes de repérage, pour les syndromes respiratoire, cutané et gastro-intestinal, de patients avec une infection à risque épidémique à partir des données du dossier médical informatisé des urgences. 3) Évaluation des données du dossier médical des urgences pour la détection d’épidémies communautaires de grippe, comparées aux données régionales de surveillance de la grippe. Résultats et Discussion. Cette thèse a montré que qu’il est possible de repérer des patients à risque épidémique avec une balance raisonnable entre la sensibilité et la spécificité pour des syndromes respiratoires et cutanés. Les algorithmes pour des syndromes gastro-intestinaux n'étaient pas assez spécifiques pour une utilisation de routine. Les données d’urgences ont permis aussi de détecter les épidémies communautaires dès le début de l’épidémie locale / Introduction. The early detection of the infections by an effective surveillance system allows implementing adapted measures of prevention and control. The objective of this thesis was to estimate the performances of an automatic system syndromic-like to detect the patients with potentially transmissible infectious diseases from the emergency department computerized medical record data. Study population. 101,001 adults, who were admitted to the emergency department and hospitalised of the North Hospital In University Hospital of Lyon, between 01/06/2007 and 30/03/2011. Method. Three steps were necessary. 1) Evaluation of the feasibility to use the structured and textual data with an application which automatically extracts and encodes information found in narrative reports. 2) Different algorithms were built for the detection of patients with infectious respiratory, cutaneous or gastrointestinal syndromes, and assessed. 3) Evaluation of the data of the electronic medical record of emergency department for the detection of flu community epidemics, compared with regional surveillance networks for flu. Results and discussion. This thesis showed that it is possible to detect patients with potentially transmissible infectious diseases with reasonable balance between sensitivity and specificity for respiratory and cutaneous syndromes. The algorithms for gastrointestinal syndromes were not specific enough for their routine use. Emergency department data enabled the detection of community outbreaks for flu

Diss. (sammanfattning) Linköping : Linköpings universitet, 2005. / Härtill 5 uppsatser.

Abstract Pneumonia is a common diagnosis for intensive care unit (ICU) admission. In 2012, 51% of the ICU-treated infections in Finland were of pulmonary origin. The ICU-treated pneumonias can be classified according to acquisition of infection as community-acquired (CAP) or hospital-acquired (HAP). Ventilator-associated pneumonia (VAP) is a subtype of HAP. Patients with severe community-acquired pneumonia (SCAP) require ICU treatment due to need of mechanical ventilation or hemodynamic support. SCAP is associated with high morbidity and high ICU and hospital mortality. The aim of this observational study was to evaluate the clinical characteristics and outcome of SCAP, with special interest on imaging, viral etiology, combination antibiotic treatment and long-term outcome. The thesis comprises three retrospective studies with altogether 392 SCAP patients, median age 55 years, 55.9% of them male. The usefulness of early chest CT and β-lactam-respiratory quinolone (βQ) versus β-lactam-macrolide (βM) therapy for SCAP treatment was evaluated. The hospital and long-term outcomes of SCAP patients were compared with 66 HAP and 25 VAP cases. A prospective study included 49 mechanically ventilated SCAP patients. The frequency of viral etiology in SCAP was analyzed. In SCAP patients, the chest CT as compared to the chest radiograph yielded new imaging findings for 58.5% of the SCAP patients. This information led to procedures or treatment changes in 43% of the cases. The severity of oxygenation disorder correlated to the extent of lung involvement. In prospective SCAP series ICU- mortality was 6.1% and hospital mortality was 12.2%. Viral etiology was found to be common in SCAP and viruses were demonstrated in 49% of patients. The outcome was similar whether SCAP patients were treated with βQ or βM combination. The type of pneumonia did not have a significant association with hospital mortality in ICU-treated SCAP, HAP and VAP patients. Among the hospital survivors, the long-term mortality was substantial, SCAP patients representing the best 1-year outcome. In conclusion, early CT might be useful in SCAP diagnostics and treatment. Viral etiology is common in SCAP. Both β-lactam-respiratory quinolone and β-lactam macrolide combinations were equally good in SCAP treatment. Hospital mortality did not differ among ICU-treated pneumonia cases, but SCAP had the best long-term survival. / Tiivistelmä Keuhkokuume on yleinen tehohoitoon johtava tulehdussairaus. Suomessa vuonna 2012 teho-osastolla hoidetuista infektioista 51&#160;% oli keuhkoalkuisia. Keuhkokuume luokitellaan hankintapaikan mukaan kotisyntyiseksi (CAP) tai sairaalasyntyiseksi (HAP). Hengityslaitehoitoon liittyvä keuhkokuume (VAP) on sairaalasyntyisen keuhkokuumeen alatyyppi. Vakavalla kotisyntyisellä keuhkokuumeella (SCAP) tarkoitetaan vaikeaa keuhkoinfektiota, joka vaatii hengityslaitehoitoa tai verenkierron tukihoitoa teho-osastolla. SCAP:iin liittyy korkea sairastuvuus sekä tehohoito- ja sairaalakuolleisuus. Tässä havainnoivassa kliinisessä tutkimuksessa selvitettiin SCAP:n kliinistä kuvaa ja ennustetta. Erityishuomion kohteena oli varhaisvaiheessa suoritetun keuhkojen tietokonekerroskuvauksen (CT), keuhkokuumeen aiheuttajamikrobien ja antibimikrobihoidon vaikutus taudin hoitoon ja ennusteeseen sekä tehohoidettujen keuhkokuumepotilaiden pitkäaikaisennuste. Väitöskirja koostuu kolmesta retrospektiivisestä osatyöstä, joissa oli yhteensä 392 SCAP-potilasta. Potilaiden mediaani-ikä oli 55 vuotta ja heistä 55,9&#160;% oli miehiä. Varhaisvaiheen keuhkojen CT:n sekä beetalaktaami-kinoloni- ja beetalaktaami- makrolidi-yhdistelmähoidon vaikutusta keuhkokuumeen hoitoon arvioitiin retrospektiivisesti. SCAP-potilaiden sairaalakuolleisuutta ja pitkäaikaisennustetta verrattiin 25:n VAP- ja 66:n HAP-potilaan ennusteeseen. Prospektiivisessa tutkimuksessa oli 49 hengityskonehoidettua potilasta. Tutkimuksessa tarkasteltiin virusten osuutta ja merkitystä vaikeassa SCAP:ssa. Keuhkojen CT havaitsi 58,5&#160;%:lla SCAP-potilaista löydöksiä, joita ei todettu keuhkojen natiiviröntgentutkimuksessa. Löydökset johtivat toimenpiteisiin 43&#160;%:lla SCAP-potilaista. Happeutumishäiriön vaikeusasteen ja CT:llä todettujen keuhkojen tulehdusmuutosten laajuuden välillä havaittiin yhteys. Virusetiologia on SCAP:ssa yleinen. Viruksia havaittiin 49&#160;%:lla SCAP-potilaista. Beetalaktaami-kinoloni- ja beetalaktaami-makrolidi -yhdistelmähoidon välillä ei havaittu eroa SCAP-potilaiden ennusteessa. SCAP-, HAP- ja VAP-potilaiden ennustevertailussa keuhkokuumetyypin ei todettu vaikuttavan sairaalakuolleisuuteen. Paras yhden vuoden ennuste oli SCAP-potilailla. Yhteenvetona todettakoon, että varhaisvaiheen keuhkojen CT on hyödyllinen SCAP:n hoidossa. Virukset ovat yleisiä SCAP:n aiheuttajamikrobeja. Molemmat tutkitut antimikrobiyhdistelmät todettiin hyviksi SCAP:n hoidossa. Sairaalakuolleisuus ei eroa keuhkokuumealatyyppien välillä, mutta SCAP- potilailla on paras pitkäaikaisennuste.

Research Abstract Purpose: to explain how there is a direct correlation between nursing staff ratios and patient results regarding mortality, infection, poor patient safety, and other sentinel events. Aims: how is patient care compromised by nursing staff shortage? Methods: observational studies from public information records such as Medicare patient claims, AHA, and surveys from RNs working at acute care hospitals. Results: certain groups are more susceptible to sentinel events. Patients with chronic diseases, elderly, patients needing intensive care, or overall unstable patients are examples of patients who fall under this category. Studies show that patients are at higher risk for receiving detrimental care due to poor nurse to patient ratio. Conclusions: adding to a nurse’s workload increases patient mortality in length of stay in hospitals due to hospital administration only needing to meet the minimum staffing requirements. The minimum staffing required for operations still does not meet the recommendations provided by the Safe Staffing Act. Key Words: nurse shortages, patient safety, patient outcomes, healthcare quality, workload, hospital acquired infections, staffing, CAUTI, VAP, CABI